These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23873109)

  • 1. The cyclin D1 (CCND1) G870A polymorphism and lung cancer susceptibility: a meta-analysis.
    Zhou C; An H; Hu M; Liu Q; Geng P; Xu J; Sun B; Liu C
    Tumour Biol; 2013 Dec; 34(6):3831-7. PubMed ID: 23873109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: a meta-analysis comprising 20,271 subjects.
    Chen B; Cao L; Yang P; Zhou Y; Wu XT
    Cancer Epidemiol; 2012 Apr; 36(2):106-15. PubMed ID: 21606015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.
    Xie M; Zhao F; Zou X; Jin S; Xiong S
    Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis.
    Liu J; Liao Q; Zhang Y; Sun S; Zhong C; Liu X
    Tumour Biol; 2012 Oct; 33(5):1467-76. PubMed ID: 22528945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.
    Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z
    PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis.
    Zhang Y; Zeng X; Lu H; Ji H; Zhao E; Li Y
    Oncotarget; 2016 Oct; 7(40):66109-66118. PubMed ID: 27623072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 (CCND1) G870A polymorphisms and cervical cancer susceptibility: a meta-analysis based on ten case-control studies.
    Wu Y; Fu H; Zhang H; Huang H; Chen M; Zhang L; Yang H; Qin D
    Tumour Biol; 2014 Jul; 35(7):6913-8. PubMed ID: 24737585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCND1 G870A polymorphism interaction with cigarette smoking increases lung cancer risk: meta-analyses based on 5008 cases and 5214 controls.
    Duan YZ; Zhang L; Liu CC; Zhu B; Zhuo WL; Chen ZT
    Mol Biol Rep; 2013 Jul; 40(7):4625-35. PubMed ID: 23653001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls.
    Hu YY; Zheng R; Guo C; Niu YM
    Diagn Pathol; 2014 Sep; 9():168. PubMed ID: 25204741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population.
    Chen X; Zhao T; Li L; Xu C; Zhang X; Tse V; Zhang T; Liu X; Lu F
    DNA Cell Biol; 2012 Jun; 31(6):1107-13. PubMed ID: 22304571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis.
    Tan XL; Nieters A; Kropp S; Hoffmeister M; Brenner H; Chang-Claude J
    Int J Cancer; 2008 Jun; 122(11):2573-80. PubMed ID: 18196581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Cyclin D1 polymorphism and oral cancer susceptibility: a meta-analysis.
    Wang L; Wang Z; Gao X; Li X; Sun X; Liu C
    Tumour Biol; 2014 Feb; 35(2):1149-55. PubMed ID: 24186074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between
    Thakur N; Kumari S; Mehrotra R
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30361291
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclin D1 G870A polymorphism contributes to colorectal cancer susceptibility: evidence from a systematic review of 22 case-control studies.
    Yang Y; Wang F; Shi C; Zou Y; Qin H; Ma Y
    PLoS One; 2012; 7(5):e36813. PubMed ID: 22606291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AA genotype of cyclin D1 G870A polymorphism increases breast cancer risk: Findings of a case-control study and meta-analysis.
    Akhter N; Alzahrani FA; Dar SA; Wahid M; Sattar RSA; Hussain S; Haque S; Ansari SA; Jawed A; Mandal RK; Almalki S; Alharbi RA; Husain SA
    J Cell Biochem; 2019 Oct; 120(10):16452-16466. PubMed ID: 31243808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CCND1 G870A polymorphism and susceptibility to bladder cancer.
    Li J; Luo F; Zhang H; Li L; Xu Y
    Tumour Biol; 2014 Jan; 35(1):171-7. PubMed ID: 23893383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional role of CyclinD1 polymorphism (G870A) in modifying susceptibility and overall survival of North Indian lung cancer patients.
    Pandey A; Bahl C; Sharma S; Singh N; Behera D
    Tumori; 2018 Jun; 104(3):179-187. PubMed ID: 30086699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 G870A polymorphism is a risk factor for esophageal cancer among Asians.
    Zhuo W; Zhang L; Wang Y; Zhu B; Chen Z
    Cancer Invest; 2012 Nov; 30(9):630-6. PubMed ID: 23020291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a meta-analysis.
    Li M; Dai W; Zhou H
    ScientificWorldJournal; 2013; 2013():689048. PubMed ID: 24222746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COX-2 rs5275 and rs689466 polymorphism and risk of lung cancer: A PRISMA-compliant meta-analysis.
    Li J; Lu X; Zou X; Jiang Y; Yao J; Liu H; Ni B; Ma H
    Medicine (Baltimore); 2018 Aug; 97(35):e11859. PubMed ID: 30170377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.